Introductory Chapter: Unconventional Philosophy of Herpesvirus Infections by Ongrádi, Joseph
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 1
Introductory Chapter: Unconventional Philosophy of
Herpesvirus Infections
Joseph Ongrádi
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/64818
The course of herpesvirus infection in human and animals is not so simple as it has been
presumed on the analogy of other microbes at the beginning of virology era. Classification into
acute and chronic infections, simple distinction of complete clinical and virological recovery
or perishing of the host organism belong to the conventional views on the course and outcome
of virus infections. But several other forms of existence of herpesviruses (HHVs) in the host
are possible. Many diverse interactions between the macro-organism and herpesviruses have
been discovered gradually. In spite of these new data, conventionally, the idea about one
organism causing one well-characterized disease has remained in the mind of the majority of
both many medical, veterinary professionals and the public. Nowadays we believe that we
understand the pathomechanism of herpesviral diseases. Simply saying, this is not true,
because, frequently we encounter new experimental evidence that cause surprise and contin‐
uously modify dogmas. The conventional way of our thinking on host-viral interaction is
somewhat static, but the life-long flow of events between invading herpesviruses and the
defensive organism is dynamic: several alternative ways on both sides might influence
outcome. Furthermore, their bilateral interplay is modified by many intrinsic and extrinsic
factors, consequently it is rather multilateral. This moment there are delicate methods to follow
post-infection events at the molecular level. Beside structural polypeptides, herpesviruses
encode a large number of proteins with enzymatic or regulatory functions. The exact way of
regulating their activities by post-translational modifications, e.g. glycosylation or phosphor‐
ylation, is hardly explored. Events at sub-molecular level and energy flow during assembly of
their structural components are almost unknown. Basic physics, not conventional virology
could help supply knowledge in these matters. Data processing by computers analyses tens
of thousands of data obtained in one model experiment or clinical cohorts including large
number of patients, but in future we have to extrapolate their pathophysiological meaning to
clinical relevance. It is surprising at the first glance, that the same herpesvirus species can
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contribute to both acute clinical picture exhibiting characteristic symptoms (vesicles, rash,
fever, etc.), and chronic, debilitating diseases without apparent virus production (tumours,
autoimmune diseases, etc.). Similarly, related herpesviruses could induce the same clinical
symptoms, as herpes simplex virus (HSV) 1 and 2, or cytomegalovirus (CMV) and Epstein-
Barr virus (EBV), or HHV-6B and HHV-7. These suggest that our detecting systems are not
fine enough to distinguish only superficially identical processes. We are on a good path to
reveal the importance of genetic background, namely, polymorphism of both the virus and its
host in the course of pathogenesis. Latency, persistence can be regarded as a balanced state
between herpesviruses and animals. Instead of complete gene expression and virion produc‐
tion, partial gene expression evolved through phylogenesis and co-evolution by the host and
its herpesviruses. Even maintenance of episomal latency of herpesviruses is not a passive
process, it requires active viral gene expression as it has been shown in the case of Epstein-
Barr virus and herpes simplex virus. Partial gene expression was described in EBV-associated
or Kaposi sarcoma herpesvirus (KSHV)-associated tumours several decades ago. Both life-long
latency without activation and malignant transformation of cells and consequent contribution
to tumour induction and progression are a dead end for the virus along with the perishing
host instead of replication and spreading to the environment to find new hosts. Another
unusual aspect of herpesvirus pathogenicity is that in 0.2–0.85% of the human population
HHV-6A and HHV-6B are integrated in the telomeric region of human chromosomes, and
transmitted vertically by standard Mendelian inheritance or by any cell donation [1]. The time
and mode of integration in our ancestors are unknown. Some of the carrier persons suffer from
neurological symptoms for several years with remittances and relapses [2]. At this moment it
is not known whether the life span is modified by HHV-6 species. In combatting defence
mechanisms of the organism, different herpesviruses developed cascade mechanisms to mimic
several molecular events hijacked from their host. Among alternative infection strategies these
are regarded as parts of immune evasion. Can we introduce similar or other human host genes
into herpesvirus vaccines to improve their efficacy? Can we introduce genes of animal origin
into a human or animal herpesvirus vaccine? Would it be dangerous or unethical? How to
select a human gene donor? There are attempts to use HHV-7 as a vector to treat genetic
disorders, because this virus has been regarded as ubiquitous and harmless. But lately several
clinical reports have shown that it reactivates in the recipients after solid organ transplantation
and aggravates CMV disease. In bone marrow or stem cell transplant recipients, usually in
small children with leukemias, it also reactivates, and can elicit a very severe, frequently lethal
encephalitis. Delayed primary HHV-7 infection in adults might result in a generalized
infection, tetraplegia and encephalitis [3]. Conventional common belief about HHV-7 has been
turned to the opposite direction in a few years of time.
To find new host cells, cell-to-cell spread is a convenient way. Some herpesviruses are regard‐
ed as cell associated, but the exact molecular cascade in this process has not been elucidated yet.
So far, we have known that alteration of the function of neighbouring cells or distant cells is
mediated by soluble mediators, cytokines and chemokines. Discovery of micro-vesicles and
exosomes that can contain fragments of viral nucleic acid, mRNAs and microRNAs with
regulatory potential will change our ideas about the regulation of the whole body of a macro-
organism by viruses. These vesicles are released from infected cells to the microenvironment or
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the circulation, and are taken up by another cells in the vicinity or very far in the body,
subsequently they induce further pathological changes that have not directly been credited with
virus infections so far. Accumulating evidence suggests that this mechanism is widely used by
human herpesvirus species. Exosomes released from HSV-1-infected cells can contain viral
polypeptides (gH, gD). Interestingly, they contain modified tegument and envelope proteins
that usually originate from the light particles of HSV. Tegument proteins outside the nucleo‐
capsid exert very important regulatory functions. Such content of exosomes promote spread
and latency by HSVs. CMV-infected cells release exosomes with cellular molecules that are
necessary for virus uptake. These might contribute to allograft rejection in transplant recipi‐
ents. Exosomes released from HHV-6-infected cells transfer MHC I molecules in addition to
complete viral particles. This latter is an absolute viral journey in disguise throughout the whole
body, even crossing the blood-brain barrier. Furthermore, growth factors that are very important
in EBV pathogenesis can be shuttled into exosomes. Viral antigens in the absence of apparent
EBV replication can be transferred to other cells, consequently they can induce autoimmune or
other diseases. Exosomes produced by KSHV-infected cells can carry both cellular and viral
mRNAs promoting sarcoma metastases.  All  these phenomena contribute to the transient
infection, a newly recognized form of viral existence in the body (see references in [4]).
The structure of herpesviruses comprising the nucleocapsid, tegument and envelope resem‐
bles the cellular nucleus, cytoplasm and cell membrane, respectively [5]. The regular belief is
that the effect of viruses on cells starts when virus genes are expressed in the cells. Really, this
effect starts much earlier, when virions attach to receptors and co-receptors instructing them
to send fake messages to reprogram cellular machinery.
Asymptomatic virus shedding is very common in all herpesvirus infections. At the population
level, it can be difficult to establish the source and time of infection, e.g. in contract tracing, to
find and prove the possible donor in certain cases, even in the court, decades later, or to describe
viral epidemiology. Simultaneous herpesvirus infections, or in the presence of one species in
the body, a super-infection by another herpesvirus species might occur. In such events, direct
interaction in the same host cells or indirect interaction between different cells infected by
distinct viruses can take place, resulting in intracellular or trans-cellular transactivation
between two competent viruses. Interactions among herpesviruses promote reactivation from
latency, profoundly modify innate immunity and T-cell activity, only a few facts to mention
[6]. Interaction of herpesviruses with other viruses has gained clinical importance lately,
especially in AIDS patients. All human herpesvirus species are involved in the one way or
mutual transactivation with HIV facilitating AIDS progression. Especially β- and γ-herpesvi‐
ruses are able to transactivate other unrelated viruses, bacteria and parasites [7]. The net effect
of transactivation is neither additive nor synergistic; new formulas have to be created for their
mathematical modelling. It is conceivable that formulas will depend on actual virus pairs.
These phenomena listed above could be regarded as crossroads of epidemiology: the unknown
source and time of infection by the participating viruses pose a nightmare to classical epi‐
demiologists.
The simplest question is: do animals including human contain a normal virus flora similarly
to the normal bacterial flora? Latency, persistence of herpesviruses with asymptomatic
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shedding but without apparent harm to the host might suggest an answer: yes [6]. But
appearance of clinical symptoms, tumours, even causing acute lethal complications by the
same reactivated viruses imply no. No sharp distinction, a clear answer can be made regard‐
ing our virome. It is important for human to undergo several bacterial infections during the
early period of our life cycle: some microbes establish the normal flora and all of them induce
some form of immunity (e.g. systemic, mucosal). Their presence in the body and wide range
effects significantly exceeds these simple facts. It seems that it is also important to acquire
herpesvirus infections in early childhood. These infections are usually asymptomatic or mild
conferring protection against super-infection. Delayed primary herpesvirus infections of
seronegative individuals usually are accompanied by severe clinical manifestations. The order
of sequential primary infections could be regulated. A simple example is shown by HSV-1
infection in infants, HSV-2 infection in adolescents or HHV-6B infection around 6 months of
age, HHV-7 infection around 3 or 4 years of age in spite of the same, salivary route of
transmission. The exact mode of regulation is absolutely unknown. Unfortunately, rapidly
changing life style and other social factors not only disturb but disrupt these well establish‐
ed, conserved biological processes [3].
Herpesviruses easily adapted themselves to different animals, and through co-evolution with
the given host an equilibrium has established for the compromise of both partners. The
interaction is very intimate and varies by both herpesvirus species and the host macro-
organism. That is one of the reasons why studies on herpesvirus pathogenesis has been
hindered by the lack of appropriate animal models, and this is especially true for β-herpes‐
virinae and γ-herpesvirinae.
From these examples taken arbitrarily, it is conceivable that herpesviruses must not be
regarded as conventional parasites, their existence in the body is neither mutualism nor
commensalism, rather it is challenging to regard them as unconventional pathogens.
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